We’re pleased to announce the online publication of Phase 3 PROMIS I and II study results in The Lancet Respiratory Medicine. Non-cystic fibrosis bronchiectasis, or #NCFB, is a chronic lung disease characterized by recurrent infection, inflammation, persistent cough, and production of sputum, and its prevalence is increasing worldwide. We extend our gratitude to the patients, families and researchers who dedicated their time to participate in the PROMIS clinical program. Learn more: https://lnkd.in/dUi8RXGw #Bronchiectasis #Oxygen #ChronicIllness #LungDisease #LungHealth #LungTransplant #PulmonaryDisease
Zambon
Fabbricazione di prodotti farmaceutici
Bresso, Milano 202.556 follower
Since 1906 our mission is innovating Cure & Care to make patients’ lives better.
Chi siamo
Zambon is a chemical-pharmaceutical company founded on the history and values of an Italian family and committed to innovating cure & care to improve patients’ lives. Present in Europe, America and Asia with over 2,900 employees and manufacturing units in Italy, Switzerland, France, China and Brazil, in 2023 the Group revenues amounted to 899 million euros. Zambon SpA, the pharma subsidiary of the group with its 23 branchess and products commercialized in 87 countries, has taken a new role in the industry. In addition to pain and diseases of the respiratory system and urological system, Zambon is establishing a global pipeline and introducing important treatments for serious diseases such as Parkinson’s Disease, Cystic Fibrosis, BOS and NCFB. In recent years the Group established ZBiotech, a specialized biotech company that aims to build a scientifically robust and commercially viable portfolio of innovative patient-oriented drugs through the scouting, acquisition, licensing and development of new molecules. Zambon also produces high quality products thanks to the management of the whole production chain which involves Zach-Zambon Chemicals, a privileged partner for API, custom synthesis and generic products. Zambon complements the offering of medicines with modern health solutions. Through Zcube-Zambon Research Venture it actively scouts and supports the growth of innovative projects and startups. Among them, in 2018 Zcube founded Careapt which develops integrated Hi-Tech/Hi-Touch solutions for chronic disease management. The Zambon group also includes ItaliAssistenza, a Home Care Company involved in the design and delivery of patient support programs (PSP) and home care services. Zambon was established in 1906 in Vicenza and is headquartered in Milan within OpenZone, the scientific campus where knowledge is shared between partners in the field of Healthcare, founded with the aim to transform research into enterprise.
- Sito Web
-
http://www.zambon.com
Link esterno per Zambon
- Settore
- Fabbricazione di prodotti farmaceutici
- Dimensioni dell’azienda
- 1001 - 5000 dipendenti
- Sede principale
- Bresso, Milano
- Tipo
- Società privata non quotata
- Data di fondazione
- 1906
- Settori di competenza
- Pharmaceutical, Respiratory, Pain, Woman Healthcare and Central Nervous System
Località
-
Principale
Via Lillo del Duca, 10
Bresso, Milano 20091, IT
-
-
Via della Chimica, 9
Vicenza, Ven. 36100, IT
Dipendenti presso Zambon
Aggiornamenti
-
As the ERS Congress 2024 in Vienna comes to an end, we would like to thank everyone who took the time to visit our booth and engage in meaningful discussions. A special thank you to our dedicated colleagues who represented Zambon with passion and expertise at this prestigious event. Looking ahead, the ERS Congress 2025 will be held in Amsterdam, and we hope to see you there as we continue working toward improving respiratory health. Stay tuned for more updates and exciting developments from Zambon! #ERSCongress2024 #RespiratoryHealth #Zambon #PharmaInnovation #Vienna #Amsterdam #ERSCongress2025
-
🌍 World Cystic Fibrosis Day 🌍 Today, we join the global community to raise awareness of Cystic Fibrosis (CF), the most common severe genetic disease affecting around 70,000 people worldwide. CF is caused by a faulty gene that affects salt and water movement in cells, leading to thick mucus buildup in the lungs and digestive system. This causes recurring infections and a progressive decline in lung function. Thanks to advances in research and care, life expectancy has significantly improved, offering new hope to patients and their families. #CysticFibrosis #WorldCysticFibrosisDay #RareDisease #RespiratoryHealth #Zambon #65roses
-
We are #hiring! Zambon is looking for a Global Customer Manager reporting to the Global Customer Lead. The role will support the implementation and deployment of the Customer Engagement Plan both for Pharmacists and Doctors (GPs and Specialists) and will also act as a partner for all local Customer Team to further harmonize processes, methodologies and governance. Apply now and join our team!
-
As the seasons change, respiratory infections like coughs and colds become more common. These can lead to serious complications, particularly in vulnerable populations. Zambon is dedicated to respiratory health, offering effective treatments to manage symptoms and improve quality of life. Stay vigilant by washing your hands regularly, staying hydrated, and seeking medical advice when needed. #RespiratoryHealth #StayHealthy #FightInfections #SeasonalWellness
-
Zambon will be attending the European Respiratory Society (ERS) Congress 2024, happening in Vienna from September 7-11. Join us at Booth C5.02, where we’ll be presenting our latest advancements in respiratory health, emphasizing our ongoing commitment to enhancing patient care worldwide. Stay connected for updates and insights from the Congress. #ERSCongress2024 #RespiratoryHealth #Zambon #PharmaInnovation #Vienna
-
We are #hiring! Zambon is looking for a "Pharma Financial Planning & Reporting Sr. Analyst" to join the "Financial Planning & Analysis" Centre of Excellence, in the Corporate Team. Apply now and join our team!
-
Zambon will be participating in the European Respiratory Society (ERS) Congress 2024, taking place in Vienna from September 7-11. Visit us at Booth C5.02, where we will showcase our latest innovations in respiratory health, reaffirming our commitment to improving patient care worldwide. During the congress, Zambon will present two scientific posters: "Trends in survival and CLAD rates after lung transplantation in Europe" and "Evolving trends in underlying etiologies for lung transplantation in Europe and outcomes." These presentations will provide insights into the latest developments in lung transplantation across Europe. Stay tuned for updates and insights from the Congress. #ERSCongress2024 #RespiratoryHealth #Zambon #PharmaInnovation #Vienna
-
We are #hiring! Zambon SpA is looking for an Industrial Business Operations (IBO) Group Controller that will lead the operating cost analysis and the industrial controlling activities of the divisional industrial controllers and the local plant controllers. Apply now and join our team!
-
Zach – Zambon Chemicals at ChemOutsourcing 2024, 3-6 September. Meet Zach at ChemOutsourcing 2024 and schedule a meeting with Nicolas Girard, Commercial Director at Zach, at our booth #52. #chemoutsourcing #Chemoutsourcing2024